Administering durvalumab before and after CRT did not provide a benefit over CRT alone in a phase 3 trial of patients with intermediate- and high-risk oropharyngeal cancer.

Please provide your email address to receive an email when new articles are posted on . HPV testing rates in oropharyngeal cancer have increased over time but remain suboptimal. Testing uptake varies ...

March 30, 2010 — The incidence of oropharyngeal carcinoma related to human papillomavirus (HPV) has been increasing in recent years, and there is speculation that this is the result of the "sexual ...

I have heard that the vaccination is being used to make women infertile and reduce the population of Muslims,” Ali Sheikh, a ...

AJCC9V staging system showed superior hazard consistency, outcome prediction, and balance, but not hazard discrimination. HealthDay News — Version 9 of the American Joint Committee on Cancer (AJCC) ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...

November 6, 2008 — Human papillomavirus (HPV) infection has recently been established as an important risk factor for oropharyngeal cancers. Using a noninvasive oral rinse, researchers have now ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low rates of side effects for people ...

According to a 2021 study published by the American Cancer Society, African Americans have a higher risk of developing oral cancer and a higher likelihood of dying from it compared to white Americans.